Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Inverness Medical Innovations, Inc. (Inverness Medical) has reported net revenues of $460.4 million for the second quarter of 2009, compared with the net revenue of $401.1 million in the year-ago quarter. It also reported GAAP net income of $4.5 million, or $0.02 per diluted share, for the second quarter of 2009, compared with the GAAP net loss of $30.3 million, or $0.43 loss per diluted share, in the year-ago quarter.
Subscribe to our email newsletter
The revenue increase was primarily due to $34.2 million of incremental revenue provided by our Health Management segment principally as a result of incremental revenues from recently acquired businesses, along with $14.5 million of incremental revenue contributed by our other recently acquired businesses, offset in part by the adverse impact of foreign currency translation which reduced reported revenues by $15.6 million. The recent H1N1 flu outbreak resulted in an increase in sales of our influenza tests by $13.9 million from the second quarter of 2008. Excluding the impact of the flu increase, the currency adjusted organic growth rate in our Professional Diagnostics segment was approximately 6%.
The company reported adjusted cash basis net income available to common stockholders of $47.6 million, or $0.57 per diluted common share, for the second quarter of 2009, compared to adjusted cash basis net income available to common stockholders of $29.6 million, or $0.37 per diluted common share, for the second quarter of 2008.
Inverness Medicalis a developer, manufacturer and marketer of medical diagnostic products.